Distribuzione geografica
Continente #
NA - Nord America 5.997
EU - Europa 1.182
AS - Asia 823
AF - Africa 7
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.012
Nazione #
US - Stati Uniti d'America 5.995
CN - Cina 394
TR - Turchia 270
UA - Ucraina 244
IT - Italia 242
DE - Germania 176
PL - Polonia 158
GB - Regno Unito 125
SE - Svezia 122
SG - Singapore 109
FI - Finlandia 84
ID - Indonesia 21
VN - Vietnam 11
FR - Francia 10
CZ - Repubblica Ceca 7
IN - India 7
SD - Sudan 6
BE - Belgio 5
HK - Hong Kong 4
NL - Olanda 3
AU - Australia 2
CA - Canada 2
JP - Giappone 2
BG - Bulgaria 1
CH - Svizzera 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
IL - Israele 1
IR - Iran 1
KR - Corea 1
LT - Lituania 1
RO - Romania 1
SA - Arabia Saudita 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 8.012
Città #
Fairfield 899
Woodbridge 794
Houston 593
Ann Arbor 434
Chandler 418
Jacksonville 403
Ashburn 385
Seattle 348
Cambridge 301
Wilmington 290
Izmir 171
Warsaw 158
Nanjing 108
Milan 98
Princeton 98
Boardman 96
Singapore 71
San Diego 69
Beijing 67
Dearborn 45
Ferrara 42
Addison 41
Nanchang 41
Falls Church 38
Boydton 31
Shenyang 27
Hebei 26
Des Moines 23
Shanghai 22
Jakarta 21
Jiaxing 21
Mountain View 21
Redwood City 17
Bursa 15
Changsha 15
Tianjin 14
Norwalk 13
Rome 13
Dong Ket 11
Kunming 11
London 9
Los Angeles 9
New York 9
Lanzhou 8
Tappahannock 8
Jinan 7
Orange 7
Changchun 5
Pisa 5
Auburn Hills 4
Brussels 4
Filago 4
Indiana 4
Kilburn 4
New Delhi 4
San Francisco 4
Walnut 4
Albano Laziale 3
Detroit 3
Florence 3
Guangzhou 3
Khartoum 3
Lappeenranta 3
Mezzolombardo 3
Olomouc 3
Perugia 3
Stockholm 3
Washington 3
Zhengzhou 3
Ansbach 2
Chengdu 2
Chicago 2
Chiswick 2
Hefei 2
Helsinki 2
Hong Kong 2
Lawrence 2
New Bedfont 2
Paris 2
Philadelphia 2
Phoenix 2
Prescot 2
Pune 2
Redmond 2
Shaoxing 2
Simi Valley 2
Toronto 2
Trieste 2
Birmingham 1
Bologna 1
Brno 1
Bucciano 1
Capri 1
Caserta 1
Central 1
Centurion 1
Coeur d'Alene 1
Cologne 1
Council Bluffs 1
Den Haag 1
Totale 6.494
Nome #
Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen and skeletal muscle dystrophy 250
NGF steers microglia toward a neuroprotective phenotype 232
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 129
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 127
Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis 120
Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice 117
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease 114
Alzheimer-like neurodegeneration in aged antinerve Growth factor transgenic mice 114
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 113
Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice 111
Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration 110
Intranasal "painless" human nerve growth factors slows amyloid neurodegeneration and prevents memory deficits in app x PS1 mice 110
Neutralization of Nerve Growth Factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 110
A dual mechanism linking NGF/ProNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 108
Environmental enrichment delays the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 108
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 107
Dark rearing blocks the developmental down-regulation of brain-derived neurotrophic factor messenger RNA expression in layers IV and V of the rat visual cortex 106
Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus 105
A small molecule targeting the multifactorial nature of Alzheimer's disease 104
Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models 104
Pathogen-Free Husbandry Conditions Alleviate Behavioral Deficits and Neurodegeneration in AD10 Anti-NGF Mice. 103
Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation 103
ProNGF drives localized and cell selective parvalbumin interneuron and perineuronal net depletion in the dentate gyrus of transgenic mice 101
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: Mining of microarray data by logic classification and feature selection 100
null 100
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity 100
The positional identity of mouse ES cell-generated neurons is affected by BMP signaling 99
A carnivore species (Canis familiaris) expresses circadian melatonin rhythm in the peripheral blood and melatonin receptors in the brain 98
Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice 98
Differential regulation of brain-derived neurotrophic factor messenger RNA cellular expression in the adult rat visual cortex 98
Rat visual cortical neurones express TrkA NGF receptor 97
In vitro receptor binding properties of a "painless" NGF mutein, linked to hereditary sensory autonomic neuropathy type V 97
Postnatal development of GFAP in mouse visual cortex is not affected by light deprivation 96
ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 96
Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice 96
Melatonin signal transduction and mechanism of action in the Central Nervous System. Using the rabbit cortex as a model 95
Towards non invasive nerve growth factor therapies for Alzheimer's disease 95
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding 95
Development of a non invasive NGF-based therapy for Alzheimer's disease 94
Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities 94
Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice 94
Intranasal delivery of therapeutic proteins for neurological diseases 93
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 93
Nerve growth factor regulates axial rotation during early stages of chick embryo development 93
2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist 93
SorLA Deficiency Dissects Amyloid Pathology from Tau and Cholinergic Neurodegeneration in a Mouse Model of Alzheimer's Disease 93
Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody 92
Non-human transgenic animals for the study of neurodegenerative syndromes 92
Reduction of regional cerebral blood flow by melatonin in young rats 92
From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V 92
Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice 90
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 89
null 89
Mismatch between BDNF mRNA and protein expression in the developing visual cortex: the role of visual experience 88
Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons 88
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 86
Distribution and characterization of the melatonin receptors in the hypothalamus and pituitary gland of three domestic ungulates 85
Endogenous A beta causes cell death via early tau hyperphosphorylation 84
Painless Nerve Growth Factor: A TrkA biased agonist mediating a broad neuroprotection via its actions on microglia cells 82
Muscular dystrophy in adult and aged anti-NGF transgenic mice resembles an inclusion body myopathy 81
In the adult hippocampus, chronic nerve growth factor deprivation shifts GABAergic signaling from the hyperpolarizing to the depolarizing direction 81
Electrophysiological and behavioral effect of ozone on mice olfactory bulb 79
Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies 77
Long-term memantine treatment prevents behavioral deficits in a mouse model of sporadic Alzheimer's disease 77
The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model 77
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 76
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 75
Rescue of the neurodegenerative phenotype in AD11 anti-NGF mice. 72
Cholinergic striatal neurons are increased in HSAN V homozygous mice despite reduced NGF bioavailability 69
Non-human transgenic animals for the study of neurodegenerative syndromes 66
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 64
Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE 63
Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction 63
Interaction between NH2-tau fragment and Aß in AD mitochondria contributes to the synaptic deterioration 62
Antagonization of NGF in adult mice by transgenic antibodies causes progressive learning and memory impairments 62
Nerve Growth Factor regulates astrocyte physiology in vivo 59
Distribution and pharmacological characterization of melatonin receptors in the brain of the Japanese quail (Coturnix japonica) 55
Characterization of endothelinA receptors in cerebral and peripheral arteries of the rat 54
null 54
Vasoactive intestinal peptide-like immunoreactive fibers in the pineal gland of the sheep 52
Expression of the melatonin receptor in Xenopus laevis: A comparative study between protein and mRNA distribution 51
Muteins of hNGF, therapeutic uses and pharmaceutical compositions 49
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 48
null 41
Inhibitor of astrocyte TNF alpha for use in the treatment of neurological diseases 40
null 35
Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis 32
Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity 32
Graphene Promotes Axon Elongation through Local Stall of Nerve Growth Factor Signaling Endosomes 29
Nerve Growth Factor Neutralization Promotes Oligodendrogenesis by Increasing miR-219a-5p Levels 27
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 23
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve growth factor mice 22
Characterization by Gene Expression Analysis of Two Groups of Dopaminergic Cells Isolated from the Mouse Olfactory Bulb 20
Unraveling the Role of Dopaminergic and Calretinin Interneurons in the Olfactory Bulb 19
Temporal progression of ALzheimer-like neurodegeneration in mice expressing anti-Nerve Growth Factor recombinant antibodies 18
Enteric Alpha-Synuclein Inclusions, Colonic Inflammation, Increased Mucosal Permeability and Alterations of Bowel Neuromuscular Functions Precede Central Neurodegeneration in a Transgenic Mouse Model of Parkinson's Disease 18
Taking pain out of NGF: a "painless" NGF mutant with full neurotrophic activity 17
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 14
Getting Into the Brain: The Intranasal Approach to Enhance the Delivery of Nerve Growth Factor and Its Painless Derivative in Alzheimer’s Disease and Down Syndrome 14
Totale 8.179
Categoria #
all - tutte 34.242
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.242

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.998 331 79 122 335 183 236 207 167 175 75 51 37
2020/20211.227 107 74 48 145 61 113 29 147 51 200 161 91
2021/2022954 48 119 84 33 39 40 61 62 31 81 84 272
2022/20231.036 141 60 12 134 158 124 121 86 123 9 50 18
2023/2024471 53 66 19 20 24 41 10 31 3 32 16 156
2024/202524 24 0 0 0 0 0 0 0 0 0 0 0
Totale 8.229